Zobrazeno 1 - 6
of 6
pro vyhledávání: '"AL Shaimaa Ibrahim Rabie"'
Autor:
AL Shaimaa Ibrahim Rabie, Tasneem Alhomsi, Merna Mahmoud AbouKhatwa, Ethar Ahmed Mosilhy, Raga A. Elzahaf
Publikováno v:
Discover Food, Vol 4, Iss 1, Pp 1-16 (2024)
Abstract Background The best pharmacological treatments and dietary regimens for cancer continue to be a problem for public health. In the scientific field of oncology, whey protein WP is frequently used as a dietary strategy. The goal of the current
Externí odkaz:
https://doaj.org/article/616a8b207f674cfdb1060971cf4c6eea
Autor:
Hager Salah, Israa Sinan, Omar Alsamani, Lamyaa Samir Abdelghani, May Hassan ElLithy, Nazar Bukamal, Huda Jawad, Raghda R. S. Hussein, Marwa O. Elgendy, Al shaimaa Ibrahim Rabie, Doaa Mahmoud Khalil, Amira S. A. Said, Mohammad M. AlAhmad, Azza Khodary
Publikováno v:
Vaccines, Vol 11, Iss 6, p 1061 (2023)
(1) Background: During 2019, the COVID-19 pandemic was threatening healthcare services and workers, and acquiring immunity was an option to stop or limit the burden of this pandemic. Herd immunity was a top priority worldwide as the virus was spreadi
Externí odkaz:
https://doaj.org/article/25b4cc1f67b74d5ba8897b51d813ab5f
Autor:
Hager Salah, AL Shaimaa Ibrahim Rabie, Amira S. A. Said, Mohammad M. AlAhmad, Ahmed Hassan Shaaban, Doaa Mahmoud Khalil, Raghda R. S. Hussein, Azza Khodary
Publikováno v:
Healthcare, Vol 11, Iss 6, p 888 (2023)
Background: The outbreak has harmed patients with multiple comorbidities and chronic conditions. The pandemic’s psychological impact is thought to change their routine of seeking medical care. Research Question or Hypothesis: During COVID-19, patie
Externí odkaz:
https://doaj.org/article/579068b73198427997e5cfd0e469065d
Autor:
Al Shaimaa Ibrahim Rabie, Hager Salah, Amira S. A. Said, Ahmed Hassan Shaaban, Lamya Mohamed Abdou, Doaa Mahmoud Khalil, Zelal Kharaba, Hala Afifi, Mahmoud R. Sofy, Eman M. I. Youssef, Eman S. M. Bayoumy, Raghda R. S. Hussein
Publikováno v:
Healthcare, Vol 11, Iss 4, p 607 (2023)
There seem to currently be no therapeutic medications found for the severe coronavirus infection in 2019 (COVID-19). In light of this, it has been hypothesized that the immunomodulatory treatment known as tocilizumab can lessen the inflammatory respo
Externí odkaz:
https://doaj.org/article/07c31fd40d42418685bc09d40efb445e
Autor:
Raghda RS Hussein, Al Shaimaa Ibrahim Rabie, Maryam Bin Shaman, Ahmed Hassan Shaaban, Alzhraa M Fahmy, Mahmoud R Sofy, Elizabeth A Lattyak, Ahmed Abuelhana, Ibrahim A Naguib, Ahmed M Ashour, Mamoon A Aldeyab
Publikováno v:
The Journal of Infection in Developing Countries. 16:1679-1686
Introduction: Coronavirus disease 2019 (COVID-19) results in similar clinical characteristics as bacterial respiratory tract infections and can potentially lead to antibiotic overuse. This study aimed to determine the changes in hospital antimicrobia
Autor:
Khodary, Hager Salah, Israa Sinan, Omar Alsamani, Lamyaa Samir Abdelghani, May Hassan ElLithy, Nazar Bukamal, Huda Jawad, Raghda R. S. Hussein, Marwa O. Elgendy, Al shaimaa Ibrahim Rabie, Doaa Mahmoud Khalil, Amira S. A. Said, Mohammad M. AlAhmad, Azza
Publikováno v:
Vaccines; Volume 11; Issue 6; Pages: 1061
(1) Background: During 2019, the COVID-19 pandemic was threatening healthcare services and workers, and acquiring immunity was an option to stop or limit the burden of this pandemic. Herd immunity was a top priority worldwide as the virus was spreadi